1 citations
,
October 2017 JAK inhibitors are effective for hair regrowth in severe alopecia areata.
8 citations
,
September 2013 in “Molecular carcinogenesis” Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.
RIPK1 inhibitors might help prevent alopecia areata.
April 2021 in “Journal of Investigative Dermatology” 11 citations
,
September 2024 in “American Journal of Clinical Dermatology” Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.
5 citations
,
June 2019 in “British Journal of Dermatology” Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.
Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.
505 citations
,
October 2011 in “Journal of clinical oncology” MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.
June 2024 in “International Journal of Dermatology” Upadacitinib may effectively treat resistant lichen planopilaris.
33 citations
,
January 1997 in “Journal of Investigative Dermatology”